Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells ; day:9 ; month:7 ; year:2021 ; pages:1-15
Neurotherapeutics ; (9.7.2021), 1-15
- Creator
-
Schwichtenberg, Svenja C.
Wisgalla, Anne
Schroeder-Castagno, Maria
Alvarez-González, Cesar
Schlickeiser, Stephan
Siebert, Nadja
Bellmann-Strobl, Judith
Wernecke, Klaus-Dieter
Paul, Friedemann
Dörr, Jan
Infante-Duarte, Carmen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13311-021-01078-7
- URN
-
urn:nbn:de:101:1-2021101614124500235980
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schwichtenberg, Svenja C.
- Wisgalla, Anne
- Schroeder-Castagno, Maria
- Alvarez-González, Cesar
- Schlickeiser, Stephan
- Siebert, Nadja
- Bellmann-Strobl, Judith
- Wernecke, Klaus-Dieter
- Paul, Friedemann
- Dörr, Jan
- Infante-Duarte, Carmen
- SpringerLink (Online service)
Other Objects (12)
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
The German healthcare system
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Langfristige Therapie mit Interferon-β 1a subkutan: Klinischer Verlauf und Genexpressionsveränderungen im Blut von Patienten mit schubförmig verlaufender Multipler Sklerose
Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy
The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice
The implication of natural killer cells and neutrophils in autoimmune disorders of the central nervous system
Exercise in multiple sclerosis -- an integral component of disease management
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial